Correlation Between Design Therapeutics and Sana Biotechnology

Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Design Therapeutics and Sana Biotechnology, you can compare the effects of market volatilities on Design Therapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and Sana Biotechnology.

Diversification Opportunities for Design Therapeutics and Sana Biotechnology

0.26

Correlation Coefficient

Design Therapeutics  Sana Biotechnology

Modest diversification

The 3 months correlation between Design and Sana is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and Sana Biotechnology go up and down completely randomly.

Pair Corralation between Design Therapeutics and Sana Biotechnology

Given the investment horizon of 90 days Design Therapeutics is expected to generate 9.24 times less return on investment than Sana Biotechnology. But when comparing it to its historical volatility, Design Therapeutics is 1.62 times less risky than Sana Biotechnology. It trades about 0.04 of its potential returns per unit of risk. Sana Biotechnology is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  171.00  in Sana Biotechnology on May 6, 2025 and sell it today you would earn a total of  220.00  from holding Sana Biotechnology or generate 128.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Design Therapeutics  vs.  Sana Biotechnology

Design Therapeutics

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Design Therapeutics may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Sana Biotechnology

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Design Therapeutics and Sana Biotechnology

The main advantage of trading using opposite Design Therapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.

The idea behind Design Therapeutics and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.